Whole genome sequencing of matched primary and metastatic acral melanomas

Genome Research

Volumn 22, Issue 2, 2012, Pages 196-207

  Turajlic, Samra ^a   Furney, Simon J ^a   Lambros, Maryou B ^a   Mitsopoulos, Costas ^a   Kozarewa, Iwanka ^a   Geyer, Felipe C ^a   MacKay, Alan ^a   Hakas, Jarle ^a   Zvelebil, Marketa ^a   Lord, Christopher J ^a   Ashworth, Alan ^a   Thomas, Meirion ^b   Stamp, Gordon ^b   Larkin, James ^b   Reis Filho, Jorge S ^a   Marais, Richard ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMIDINE; TRANSCRIPTOME;

AGED; ARTICLE; CASE REPORT; ERCC5 GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; LIGHT EXPOSURE; LYMPH NODE METASTASIS; MALE; MELANOMA; MELANOMA CELL; MUTAGENICITY; NONSENSE MUTATION; ONCOGENE; PRIORITY JOURNAL; SOMATIC MUTATION; SUN EXPOSURE; ULTRAVIOLET RADIATION;

AGED; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; EXOME; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MUTATION RATE; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863393606     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.125591.111     Document Type: Article

References (68)

1. Albert SM. 2010. Neurodegenerative disease and cancer: A critical role for melanoma? Neuroepidemiology 35: 305-306.
2. Aung CS, Hill MM, Bastiani M, Parton RG, Parat MO. 2011. PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: Role of matrix metalloprotease 9. Eur J Cell Biol 90: 136-142.
3. Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH 2nd, Brocker EB, LeBoit PE, Pinkel D. 2000. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60: 1968-1973.
4. Bengtsson H, Wirapati P, Speed TP. 2009. A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6. Bioinformatics 25: 2149-2156.
5. Bengtsson H, Neuvial P, Speed TP. 2010. TumorBoost: Normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays. BMC Bioinformatics 11: 245. doi: 10.1186/1471-2105-11-245.
6. Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, Maguire J, Johnson LA, Robinson J, Verhaak RG, Sougnez C, et al. 2010. Integrative analysis of the melanoma transcriptome. Genome Res 20: 413-427.
7. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, Pflueger D, Sougnez C, et al. 2011. The genomic complexity of primary human prostate cancer. Nature 470: 214-220.
8. Bernards R, Weinberg RA. 2002. A progression puzzle. Nature 418: 823. doi: 10.1038/418823a.
9. Bertrand Y, Demeule M, Michaud-Levesque J, Beliveau R. 2007. Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo. Biochem Biophys Res Commun 353: 418-423.
10. Bowden NA, Ashton KA, Avery-Kiejda KA, Zhang XD, Hersey P, Scott RJ. 2010. Nucleotide excision repair gene expression after Cisplatin treatment in melanoma. Cancer Res 70: 7918-7926.
11. Bradford PT, Goldstein AM, McMaster ML, Tucker MA. 2009. Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986-2005. Arch Dermatol 145: 427-434.
12. Chien AJ, Moon RT. 2007. WNTS and WNT receptors as therapeutic tools and targets in human disease processes. Front Biosci 12: 448-457.
13. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, et al. 2005. Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135-2147.
14. Curtin JA, Busam K, Pinkel D, Bastian BC. 2006. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24: 4340-4346.
15. Daya-Grosjean L, Sarasin A. 2005. The role of UV induced lesions in skin carcinogenesis: An overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res 571: 43-56.
16. Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, et al. 2010. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1005.
17. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, Carnevali P, Nazarenko I, Nilsen GB, Yeung G, et al. 2010. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327: 78-81.
18. Du P, Kibbe WA, Lin SM. 2008. lumi: A pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
19. Gaddameedhi S, Kemp MG, Reardon JT, Shields JM, Smith-Roe SL, Kaufmann WK, Sancar A. 2010. Similar nucleotide excision repair capacity in melanocytes and melanoma cells. Cancer Res 70: 4922-4930.
20. Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, Mackay A, Ashworth A, Reis-Filho JS. 2010. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 220: 562-573.
21. Gomes AL, Reis-Filho JS, Lopes JM, Martinho O, Lambros MB, Martins A, Schmitt F, Pardal F, Reis RM. 2007. Molecular alterations of KIT oncogene in gliomas. Cell Oncol 29: 399-408.
22. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. 2007. Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
23. Hanafusa H, Ishikawa K, Kedashiro S, Saigo T, Iemura S, Natsume T, Komada M, Shibuya H, Nara A, Matsumoto K. 2011. Leucine-rich repeat kinase LRRK1 regulates endosomal trafficking of the EGF receptor. Nat Commun 2: 158. doi: 10.1038/ncomms1161.
24. Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. 2010. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330: 1410-1413.
25. Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, Spang R, Kunz M. 2007. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res 13: 806-815.
26. Kerbel RS, Waghorne C, Korczak B, Lagarde A, Breitman ML. 1988. Clonal dominance of primary tumours by metastatic cells: Genetic analysis and biological implications. Cancer Surv 7: 597-629.
27. Koboldt DC, Chen K, Wylie T, Larson DE, McLellan MD, Mardis ER, Weinstock GM, Wilson RK, Ding L. 2009. VarScan: Variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25: 2283-2285.
28. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. 2009. Circos: an information aesthetic for comparative genomics. Genome Res 19: 1639-1645.
29. Kumar P, Henikoff S, Ng PC. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073-1081.
30. Lambros MB, Simpson PT, Jones C, Natrajan R, Westbury C, Steele D, Savage K, Mackay A, Schmitt FC, Ashworth A, et al. 2006. Unlocking pathology archives for molecular genetic studies: A reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest 86: 398-408.
31. Lee SM, Betticher DC, Thatcher N. 1995. Melanoma: Chemotherapy. Br Med Bull 51: 609-630.
32. Lee Y, Han J, Yeom KH, Jin H, Kim VN. 2006. Drosha in primary microRNA processing. Cold Spring Harb Symp Quant Biol 71: 51-57.
33. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, et al. 2010. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465: 473-477.
34. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, et al. 2008. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456: 66-72.
35. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
36. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
37. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, London WB, Chang CH, Yu AL. 2010. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 70: 7841-7850.
38. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
39. Lucas R, McMichael T, Smith W, Armstrong B. 2006. Solar ultraviolet radiation: Global burden of disease from solar ultraviolet radiation (ed. A Pruss-Ustun et al.), Environmental burden of disease series, No. 13. World Health Organization, Geneva.
40. Maelandsmo GM, Florenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Borresen AL, Fodstad O. 1996. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br J Cancer 73: 909-916.
41. Matsui S, Utani A, Takahashi K, Mukoyama Y, Miyachi Y, Matsuyoshi N. 2008. Knockdown of Fat2 by siRNA inhibits the migration of human squamous carcinoma cells. J Dermatol Sci 51: 207-210.
42. Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, Tillement V, Pradines A, Sebti S, Favre G. 2004. Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 10: 2742-2750.
43. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. 2010. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297-1303.
44. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. 2010. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26: 2069-2070.
45. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, et al. 2008. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650.
46. Muchemwa FC, Ma D, Inoue Y, Curtin JA, Bastian BC, Ihn H, Kageshita T. 2008. Constitutive activation of the phosphatidyl inositol 3 kinase signalling pathway in acral lentiginous melanoma. Br J Dermatol 158: 411-413.
47. Nagore E, Pereda C, Botella-Estrada R, Requena C, Guillen C. 2009. Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility. Cancer Causes Control 20: 115-119.
48. Natrajan R, Weigelt B, Mackay A, Geyer FC, Grigoriadis A, Tan DS, Jones C, Lord CJ, Vatcheva R, Rodriguez-Pinilla SM, et al. 2010. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res Treat 121: 575-589.
49. Pan T, Li X, Jankovic J. 2011. The association between Parkinson's disease and melanoma. Int J Cancer 128: 2251-2260.
50. Park J, Betel D, Gryfe R, Michalickova K, Di Nicola N, Gallinger S, Hogue CW, Redston M. 2002. Mutation profiling of mismatch repair-deficient colorectal cancers using an in silico genome scan to identify coding microsatellites. Cancer Res 62: 1284-1288.
51. Parker SG, Diffey BL. 1983. The transmission of optical radiation through human nails. Br J Dermatol 108: 11-16.
52. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
53. Pfeifer GP, You YH, Besaratinia A. 2005. Mutations induced by ultraviolet light. Mutat Res 571: 19-31.
54. Phan A, Touzet S, Dalle S, Ronger-Savle S, Balme B, Thomas L. 2007. Acral lentiginous melanoma: Histopathological prognostic features of 121 cases. Br J Dermatol 157: 311-318.
55. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, et al. 2010a. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
56. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, et al. 2010b. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
57. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, et al. 2009. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461: 809-813.
58. Soikkeli J, Lukk M, Nummela P, Virolainen S, Jahkola T, Katainen R, Harju L, Ukkonen E, Saksela O, Holtta E. 2007. Systematic search for the best gene expression markers for melanoma micrometastasis detection. J Pathol 213: 180-189.
59. Takata M, Goto Y, Ichii N, Yamaura M, Murata H, Koga H, Fujimoto A, Saida T. 2005. Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas. J Invest Dermatol 125: 318-322.
60. Talmadge JE. 2007. Clonal selection of metastasis within the life history of a tumor. Cancer Res 67: 11471-11475.
61. Tokuoka M, Miyoshi N, Hitora T, Mimori K, Tanaka F, Shibata K, Ishii H, Sekimoto M, Doki Y, Mori M. 2010. Clinical significance of ASB9 in human colorectal cancer. Int J Oncol 37: 1105-1111.
62. Van Loo P, Nordgard SH, Lingjaerde OC, Russnes HG, Rye IH, Sun W, Weigman VJ, Marynen P, Zetterberg A, Naume B, et al. 2010. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci 107: 16910-16915.
63. Venkatraman ES, Olshen AB. 2007. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23: 657-663.
64. Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH. 2009. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci 106: 6279-6284.
65. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, Davis S, Stemke-Hale K, Davies MA, Gershenwald JE, et al. 2011. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43: 442-446.
66. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, KamiyamaM, Hruban RH, Eshleman JR, Nowak MA, et al. 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117.
67. Yang XR, Liang X, Pfeiffer RM, Wheeler W, Maeder D, Burdette L, Yeager M, Chanock S, Tucker MA, Goldstein AM. 2010. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma- prone families with and without CDKN2A mutations. Fam Cancer 9: 625-633.
68. Zhang P, Chan DW, Zhu Y, Li JJ, Ng IO, Wan D, Gu J. 2006. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma. Clin Cancer Res 12: 6617-6625.